Community screening for hepatitis C virus infection in a low-prevalence population.
Karen K KyuregyanElena Yu MalinnikovaNatalia V SobolevaOlga V IsaevaAnastasia A KarlsenVera S KichatovaIlya A PotemkinElena V SchibrikOlga A GadjievaBoris A BashiryanNatalya N LebedevaIgor L SerkovAnna YankinaClaudio GalliMikhail I MikhailovPublished in: BMC public health (2019)
Overall HCV prevalence is low, except in people 60 years or older. The latter should be considered as a target group for HCV screening. The high agreement between HCV RNA and HCV Ag suggests the utility of HCV Ag testing to confirm active infection in screening programs.